News

Examining Levi Strauss's Earnings Prospects and Stock Insights

Examining Levi Strauss's Earnings Prospects and Stock Insights

Understanding Levi Strauss's Earnings Potential

Levi Strauss (LEVI) is on the brink of revealing its quarterly earnings, an occasion often met with excitement and anticipation by investors. As we move closer to the earnings announcement, it is essential to reflect on key factors that could influence the company's performance and stock price.

Anticipated Earnings and Analyst Expectations

Experts foresee that Levi Strauss will announce an earnings per share (EPS) of $0.13. Investors will closely watch not just whether the company meets or exceeds this projection, but also any guidance provided regarding future growth, which can significantly impact the stock’s movement.

Past Performance Insights

Looking back, Levi Strauss beat its EPS estimate by $0.10 last quarter. However, despite the positive result, the stock encountered an 8.0% decline in the following trading day, reflecting the nuances of market reactions to earnings announcements.

Levi Strauss’s Market Performance

Currently, shares of Levi Strauss are trading at approximately $19.52, reflecting a modest 2.12% increase over the past year. Such development might give comfort to long-term investors ahead of the earnings release, indicating that the stock is holding its ground amid fluctuations.

Expert Analysts Weigh In

In today’s competitive landscape, it's crucial to stay updated on how analysts perceive Levi Strauss. According to various ratings, the consensus leans towards a recommendation to outperform. Analysts target an average price of $20.50 over the next year, suggesting a potential upside of 5.02% from current levels.

Comparative Performance with Competitors

To provide further context, it’s insightful to compare Levi Strauss with established competitors such as VF Corporation, PVH Corp, and Kontoor Brands. Each company's analyst ratings and forecasted price reflect different trajectories and growth potential.

  • VF Corp holds a neutral rating, with an average price target suggesting a potential downside of 21.26% to $15.37.
  • PVH Corp is similarly rated neutral, but with a striking upside potential of 389.24%, suggesting a target of $95.50.
  • Kontoor Brands enjoys an outperform recommendation, indicating a potential upside of 318.8% with a price target of $81.75.

Performance Metrics Overview

Understanding Levi Strauss's standings is vital for investors. Notably, in revenue growth, the company has registered a 3.15% increase, positioning it favorably against its peers. It also demonstrates a respectable gross profit margin.

Detailed Financial Analysis

Levi Strauss has various performance metrics indicating its financial health:

  • Market Capitalization: The company showcases a strong market presence with a market capitalization positioned above industry averages.
  • Revenue Growth: Demonstrating positive performance, Levi Strauss achieved a growth rate of 3.15%, surpassing many peers.
  • Net Margin: Its net margin stands at an impressive 8.84%, which underscores effective cost management.
  • Return on Equity (ROE): With a 6.74% ROE, the company showcases its effectiveness in utilizing investor capital.
  • Debt Management: Boasting a debt-to-equity ratio of 1.06 reflects Levi's prudent financial strategy, ensuring manageable debt levels.

A Closer Look at Levi Strauss

Levi Strauss & Co. is a prominent player in the apparel industry, designing and marketing an extensive range of clothing products, including jeans and casual wear, catering to men, women, and children under various brands. The company operates through key regional segments, including the Americas, Europe, and Asia, with the Americas being the dominant revenue driver.

Frequently Asked Questions

What earnings per share are analysts expecting for Levi Strauss?

Analysts expect Levi Strauss to report an EPS of $0.13 in the upcoming earnings announcement.

How did Levi Strauss perform last quarter compared to estimates?

Last quarter, Levi Strauss beat EPS estimates by $0.10 but experienced an 8.0% drop in stock price the next day.

What is the current stock price of Levi Strauss?

As of now, Levi Strauss's shares are trading around $19.52.

What is the analysts’ consensus for Levi Strauss's stock?

The consensus among analysts is to outperform, with a one-year price target averaging $20.50, indicating potential upside.

How does Levi Strauss compare to its peers?

Levi Strauss leads in revenue growth and gross profit margin compared to its peers, but it has the lowest return on equity.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Humberto Quintanar Strengthens McKinley Irvin's Seattle Team

Updated Category News Views 46

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Continue Reading
Approved Oil Secures Long-Term NYC Fuel Terminal Deal

Updated Category News Views 94

Approved Oil Locks in Future with Sunoco Deal Amidst the contraction of New York City's fuel terminal landscape, securing a consistent lifeline to crucial infrastructure feels like striking gold. Approved Oil just locked down an agreement with Sunoco for a new terminal location that'll last deep into the 2040s, and it's about more than just securing a spot on the...

Continue Reading
Columbia Distributing Expands to Alaska: A Growth Move

Updated Category News Views 33

Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...

Continue Reading
Gildan's Troubling Legal Struggles: Investor Action Alert

Updated Category News Views 60

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

Continue Reading
DropGenie Nets $5M to Boost Functional Biology Reach

Updated Category News Views 109

DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...

Continue Reading
Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 0

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 0

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
Ernesta Expands Southeast Reach with Atlanta Showroom

Updated Category News Views 85

Ernesta's Southeast Play: The Atlanta Showroom Here's something to turn heads in the world of custom home design—Ernesta has just set up shop in Atlanta, a move that speaks volumes about their ambitions in the Southeast market. This isn't just about selling a few more rugs; it's a calculated step into a region ripe with design potential and a hunger for bespoke home...

Continue Reading
Gildan Activewear Faces Major Class Action Lawsuit

Updated Category News Views 126

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Continue Reading
Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 92

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Opportunities at the 2026 China Clean Expo

Updated Category News Views 158

Welcome to the China Clean Expo 2026 The 27th China Clean Expo (CCE) is set to take place from March 31 to April 3, 2026, at the Shanghai New International Expo Center. This event, organized by IM Sinoexpo with support from notable associations, including ISSA, promises to be a hub for industry leaders, innovators, and solution providers in the cleaning sector. The...

Continue Reading
Magellan Health and Calm Health Collaboration Enhances Support

Updated Category News Views 372

Magellan Health Partners with Calm Health Magellan Health, Inc. is excited to announce a new partnership with Calm Health, aimed at providing improved mental health support for its members. This collaboration is designed to streamline the process for individuals seeking help, ensuring they receive the necessary resources in a timely manner. Understanding the Importance of...

Continue Reading
Celebrating the Visionaries: 2025 Franklin Institute Laureates

Updated Category News Views 3874

Honoring Global Innovators Across Science and Business The Franklin Institute is set to celebrate the exceptional contributions of its 2025 Franklin Institute Laureates. This illustrious occasion recognizes pioneers who have made significant advancements in science, technology, and business leadership. Among the nine distinguished honorees are trailblazers like Muyinatu...

Continue Reading
Origin Investments Launches Innovative 1031 Exchange Program

Updated Category News Views 267

Origin Investments Enters the 1031 Exchange Market Origin Investments has marked a significant milestone by completing its first acquisition under the newly established Origin Exchange program, which focuses on Delaware Statutory Trust (DST) investments. The company has acquired The Starling, a modern multifamily community featuring 300 recently developed units,...

Continue Reading
Tenaris Sees Growth Amid Challenges in Q2 2025 Financials

Updated Category News Views 263

Tenaris Reports Second Quarter Financial Results for 2025 Tenaris S.A. (NYSE: TS, BMV: TS.MX, Milan: TEN) has released its financial results for the second quarter of 2025, demonstrating resilience in a fluctuating market. Compared to the same period last year, there have been notable changes in performance metrics, illustrating both growth opportunities and challenges...

Continue Reading